Luxembourg - Peptic Ulcer and Gastro-Oesophageal Reflux Diseases (GORD) Medicine Use

Since 2014, Luxembourg Peptic Ulcer and Gastro-Oesophageal Reflux Diseases (GORD) Medicine Use increased 0.9% year on year. With 89.4 Units (Defined Daily Dosage) Per Thousand Persons Per Day in 2019, the country was number 7 comparing other countries in Peptic Ulcer and Gastro-Oesophageal Reflux Diseases (GORD) Medicine Use. Luxembourg is overtaken by Belgium, which was ranked number 6 at 100.6 Units (Defined Daily Dosage) Per Thousand Persons Per Day and is followed by Germany with 88.1 Units (Defined Daily Dosage) Per Thousand Persons Per Day. Netherlands lead the ranking with 131.7 Units (Defined Daily Dosage) Per Thousand Persons Per Day in 2019, that is an increase of 3.9% compared to 2018. Spain, United Kingdom and Iceland respectively ranked number 2, 3 and 4 in this ranking. Canada recorded the best 5 years average growth at +11.3% per year, while Austria witnessed the worst performance at -14% per year.

Loading...

Date Units (Defined Daily Dosage) Per Thousand Persons Per Day
2019 89.40
2018 89.00
2017 89.00
2016 90.20
2015 89.40
Download all data from 1999 to 2019

How does Luxembourg rank in Peptic Ulcer and Gastro-Oesophageal Reflux Diseases (GORD) Medicine Use?

# 28 Countries Units (Defined Daily Dosage) Per Thousand Persons Per Day Last YoY 5‑years CAGR
1 #1
Netherlands
132 2019 +3.9 % +3.5 % View data
2 #2
Spain
129 2019 +2.8 % +0.6 % View data
6 #6
Belgium
101 2019 +3.5 % +1.1 % View data
7 #7
Luxembourg
89 2019 +0.5 % +0.9 % View data
8 #8
Germany
88 2019 +6.3 % -0.6 % View data
Compare all 28 countries

Go Top